Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

This discovery may lead to a novel treatment approach that targets underlying brain pressure mechanisms rather than just managing symptoms. The research suggests that liraglutide, a drug originally ...

Over 12 weeks, 26 patients suffering frequent migraines and obesity received a daily dose of the GLP-1 agonist liraglutide. Remarkably, the average number of migraine days per month fell sharply ...

Blockbuster weight-loss shots like Ozempic, Wegovy and Victoza may have an unexpected side effect impacting as many as 47million Americans, a new study from researchers in Italy found.

Ozempic is approved in Canada as a treatment for type 2 diabetes, though it has garnered headlines for its off-label use as a weight-loss drug.

Ozempic and other drugs in its class are known as ... a diet drug called Mediator that started as a Type 2 diabetes treatment was taken off the market in 2009 after being blamed for thousands of ...